MKMahmoud Khodabandeh

Mahmoud Khodabandeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mahmoud Khodabandeh has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • First Infant Desensitization to Liposomal Amphotericin B

    by Maryam Rostamyan, Shirin Chinehkesh, Mahmoud Khodabandeh, Farzad Kompani

    Liposomal amphotericin B is the first-line treatment for Visceral leishmaniasis ; however, drug hypersensitivity reactions, such as anaphylaxis, can pose significant challenges. Desensitization protocols are an option when alternative treatments are lacking. A 7-month-old female infant presented with persistent fever, pallor, splenomegaly, and laboratory findings suggestive of Visceral leishmaniasis with secondary hemophagocytic lymphohistiocytosis (HLH). After developing anaphylaxis following the first dose of liposomal amphotericin B (3 mg/kg), a 14-step desensitization protocol was successfully implemented, allowing continuation of therapy without complications. After completing the course of treatment, the patient’s fever resolved, spleen size normalized, and hematological parameters improved. Causality assessment using the Naranjo scale indicated a “probable” adverse drug reaction (score = 6). This case represents the first reported successful use of a standard liposomal amphotericin B desensitization protocol in an infant under 1 year, demonstrating its feasibility and safety in managing anaphylaxis in endemic areas.

  • Ten‐Year Epidemiology and Antimicrobial Susceptibility of Pediatric Staphylococcal Scalded Skin Syndrome: A Retrospective Study From a Tertiary Referral Center

    by Mahsa Soti Khiabani, Sanaz Mohamadaghayi Talari, Mahmoud Khodabandeh

    Background/Objectives: Staphylococcal scalded skin syndrome (SSSS) is a toxin‐mediated dermatologic emergency that predominantly affects infants and young children. Despite its characteristic clinical presentation, data on long‐term epidemiologic patterns and antimicrobial susceptibility in pediatric SSSS remain limited. This study aimed to describe demographic features, microbiological findings, and antimicrobial susceptibility trends in children with SSSS over a 10‐year period preceding the COVID‐19 pandemic. Methods: We retrospectively reviewed children diagnosed with SSSS who were admitted to a tertiary pediatric referral center between 2009 and 2018. Demographic, clinical, and microbiological data were collected, and antimicrobial susceptibility results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) criteria, with methicillin susceptibility assessed using oxacillin or cloxacillin, and inducible clindamycin resistance excluded by D‐test. Results: A total of 120 children were included, the majority of whom were infants. Cases demonstrated a clear seasonal variation, with higher incidence during warmer months, although Winter represented the second most frequent season. Staphylococcus aureus was the predominant organism isolated from secretion cultures, while blood cultures were infrequently positive. No phenotypically confirmed methicillin‐resistant S. aureus was identified. Susceptibility to first‐line β‐lactam antibiotics remained high, and clindamycin susceptibility was preserved without evidence of inducible resistance. Clinical outcomes were favorable, with short hospital stays and no in‐hospital mortality. Conclusions: Methicillin‐susceptible S. aureus continues to be the principal pathogen in pediatric SSSS, with sustained susceptibility to first‐line β‐lactam agents. These findings support current empiric treatment strategies and provide a robust regional baseline for future antimicrobial resistance surveillance.

  • Open Access

    Brain Abscess Clinical Presentation, Microbiology, Management, and Outcome: Evidence from a Tertiary Pediatric Center

    by Mahmoud Khodabandeh, Roya Haghighi, AmirAli Soltani, Mahsa Soti Khiabani

    Objectives: Brain abscess (BA) is a life-threatening infection affecting the brain parenchyma. It can be caused by various microorganisms and often occurs due to underlying etiology. This study aimed to assess the clinical profile, etiology, paraclinical data, and outcomes of pediatric BA. Materials and Methods: This retrospective descriptive study was conducted at the Children’s Medical Center Hospital in Tehran, Iran, from 2010 to 2020. Diagnosis was based on clinical presentation and imaging. Data was collected for each patient from the hospital database. Results: A total of 45 patients were included in the study. The mean age of patients was 4.93 years (range: 2 months old-18 years old (216 months old) (SD: 58.16 months)), with a male-to-female ratio of 1.36:1. The most frequent clinical symptoms were vomiting, headache, and fever. Streptococcus viridans was the most common organism isolated (25%), though causative organisms were identified in only 35.5% of cases. Predisposing factors included cyanotic heart disease (CHD) (17.7%), meningitis (6.6%), and otitis media (6.6%). The most involved anatomical regions were the frontal lobe (35.5%) and then the multiple lobes (26.6%), respectively. Antibiotic treatment resulted in the cure of 23 patients (51.1%), while 22 patients (48.9%) required surgical abscess drainage in addition to antibiotics. The average hospital stay was 39 days and overall mortality was 6.66%. Conclusion: Considering BA in patients with CHD, meningitis, and otitis media helps in earlier diagnosis. Early initiation of antibiotics and selection based on the causative organism can improve BA outcomes in children.

  • The role of healthcare centers in psychosocial support of children during crises

    by Mahmoud Khodabandeh

    In times of crises such as wars or natural disasters, children are among the most vulnerable groups, often psychologically affected even in the absence of physical injuries. This letter to the editor reflects on a personal encounter with a frightened child in the emergency department, highlighting the need for psychosocial support in pediatric healthcare settings. Simple and practical strategies—such as active listening, creating comfort spaces, supporting parents, and fostering empathy—can make a significant difference in a child's recovery. Healthcare centers should be more than treatment facilities; they must be safe havens where children's psychological wounds are seen and gently tended to. Keywords: Child mental health, Crisis, Healthcare centers, Psychosocial support, Pediatric emergency, Humanitarian care

  • Open Access

    An Extremely Rare Case of Sequential Onset of Streptococcal Toxic Shock Syndrome and Kawasaki Disease Following Varicella Infection in a 2.5-Year-Old Girl

    by Mahmoud Khodabandeh, Mojtaba Gorji, Mehrnaz Olfat, Mohammadsadegh Talebi Kahdouei

    Varicella is a common viral disease of childhood that is usually benign and self-limiting, but it can lead to rare complications, including streptococcal toxic shock syndrome (STSS) and Kawasaki disease (KD). The simultaneous or sequential occurrence of these 2 complications after varicella has been reported very rarely. A 2.5-year-old girl presented with fever, swell ing, and neck erythema 5 days after varicella infection and a history of ibuprofen use. She was admitted with a diagnosis of cellulitis. Despite initial antibiotic therapy, the patient’s clini cal condition rapidly deteriorated, and she developed shock, thrombocytopenia, organ failure, and pleural effusion. The patient was transferred to the pediatric intensive care unit, intubated, and received Interavenous Immunoglobulin (IVIG). Blood culture revealed beta-hemolytic Streptococcus group A, confirming the diagnosis of STSS. After recovery and discharge from the hospital, the child presented again with fever and peeling fingertips and was admitted with suspicion of KD. Echocardiography revealed coronary artery ectasia, and she received IVIG again. The ectasia resolved on subsequent follow-up. This is one of the rarest cases of sequen tial occurrence of STSS and KD after varicella infection. Clinical attention to unusual compli cations of varicella, timely diagnosis, and appropriate treatment are essential in preventing severe and long-term outcomes in pediatric patients.

  • Open Access

    Pediatric Cervical Lymphadenitis: Etiology, Clinical Presentation, and Antimicrobial Resistance

    by Mahmoud Khodabandeh, Zahra Jam, Aryan Banai Shahani, Mahsa Soti Khiabani

    Background: Cervical lymphadenitis is prevalent in children. Several viruses and bacteria can cause cervical lymphadenitis. Staphylococcus aureus and Streptococcus pyogenes are known to predominate as bacterial causes. Choosing the effective antibiotic regimen to treat cervical lymphadenitis is difficult because of temporal and geographical variations in its etiologies and antibiotic resistance. We aim to elucidate the etiologies, treatment, and outcomes of cervical lymphadenitis in children in Iran. Methods: A total of 113 patients admitted to the Children’s Medical Center in Iran were included in this retrospective cross‐sectional study. Patients under 18 years in medical records were evaluated for demographics, signs and symptoms, lymph node aspiration or surgical drainage culture and antibiogram results, type and duration of treatment, complications, treatment failure, and patient discharge instructions. Results: Patients’ mean age was 3.5 years (SD: 2.9; range: 3 months to 13 years), and 70 (62%) were male. Of 113 patients, 38 (34%) had a prior history of upper respiratory tract infection (URI), 2 (1.7%) had dental caries, 1 (0.9%) had Hodgkin’s lymphoma, and 72 (64.1%) patients did not have any accompanying illnesses in presentation. The most common clinical manifestation was neck swelling or erythema (99.1%), followed by fever (73%), neck pain (30%), and torticollis (9%). Twenty‐one (18.5%) patients underwent cervical lymph node aspiration, and 7 (6%) underwent surgical incision and drainage, of which 17 (61%) had a positive culture. Staphylococcus aureus was isolated in 16 (94%) cases. No positive culture was reported regarding fungi and acid‐fast bacilli. Regarding their antibiogram reports, the lowest resistance rates were to vancomycin, cotrimoxazole, and oxacillin (6% each), followed by clindamycin and erythromycin (12% each) and penicillin (94%). The mean duration of hospitalization was 6 days (SD: 3.2; range: 2–22 days). Thirty‐three (29%) patients underwent surgical drainage along with antibiotic therapy. Conclusion: Cervical lymphadenitis was prevalently accompanied by URI. Swelling and erythema in the neck were the most common clinical manifestations. The most common isolated organism was Staphylococcus aureus . We did not find Streptococci, which might be due to the beta‐lactam usage before hospital admission. Most of the patients were treated with clindamycin during hospitalization. However, resistance to clindamycin was higher than that of other antibiotics effective against Staphylococci and Streptococci, like oxacillin. We recommend considering this resistance pattern in choosing antibiotics to prevent treatment failure and reduce the need for surgery.


  • Association of body mass index with COVID-19 outcome in a pediatric tertiary referral hospital in Iran

    by Mohammad Reza Abdolsalehi, Sedigheh Madani, Shima Mahmoudi, Amene Navaeian, Mahmoud Khodabandeh, Reihaneh Hosseinpour Sadeghi, Babak Pourakbari, Setareh Mamishi


  • Open Access

    Mild Symptoms of SARS-CoV-2 Infection in a 3-Days-Old Newborn with Congenital Heart Disease: A Case Report

    by Azin Etemadimanesh, Ali Ghasemi, Mahmoud Khodabandeh, Hamid Eshaghi

    Background: SARS-CoV-2 as a member of Coronavirus family, caused a global pandemic in late 2019 and raised concerns about its morbidity and mortality among immune-deficient individuals. Till now, several pediatric cases infected with SARS-CoV-2 have been reported, and some have noted susceptibility to infection in infants and young children, especially those with congenital comorbidities. In this report, we discuss the clinical course, administered treatments, and outcomes of SARS-COV-2 infection in an infant suffering from cardiovascular comorbidity. Case Presentation: We describe a newborn referred to hospital 72 hours postpartum, diagnosed with pulmonary atresia with ventricular septal defect (PA-VSD), and subsequently found to be infected with the SARS-COV-2 virus. The patient presented with tachypnea, lethargy, and a history of recent fever and myalgia in his father. He received intravenous fluid and antibiotic therapy based on an established protocol for COVID-19 treatment by Iran health ministry and was discharged after five days of hospitalization without further complications. Two weeks after discharge, he was referred to the cardiac surgery department for surgical treatment after obtaining a negative result for nasopharyngeal sample SARS-CoV-2 RT-PCR. Conclusions: Mild symptoms and no need for excessive oxygen supports in the current case demonstrate pediatrics patients with COVID-19 have a better prognosis and fewer complications compared with adults, even at early childhood and with the presence of serious cardiac complications.

  • Open Access

    Clinical Misdiagnosis of COVID-19 Infection with Confusing Clinical Course

    by Hamid Eshaghi, Vahid Ziaee, Mahmood Khodabande, Moeinadin Safavi, Elmira Haji Esmaeil Memar

    Background. Similarities in the febrile course and other manifestations of some diseases may lead to clinical misdiagnosis of COVID-19 infection. Here, we report a case in a young child with a potentially confusing clinical course. Case Presentation. A 29-month-old boy presented with a 2-month history of fever. His PCR test for COVID-19 was positive, and there was pleural effusion plus positive findings in the lower left lobe of the lung on computed tomography scan. Mid-sized splenomegaly was found on abdominal ultrasound, and laboratory tests disclosed pancytopenia. In light of the atypical lymphocyte counts in laboratory tests, he underwent bone marrow aspiration. The suggested diagnosis was hemophagocytic lymphohistiocytosis, and prednisolone was initiated. Subsequently, Leishman-Donovan bodies were seen in the bone marrow aspirate, and treatment was started with amphotericin, which led to clinical improvement. Conclusion. In cases with vague clinical symptoms in tropical countries where other infectious diseases occur, possible simultaneous infection should be considered even during a pandemic. Familiarity with the possible differential diagnoses and appropriate, step-by-step consideration to rule out other possible causes are needed in all situations, and the coexistence of infectious disease should be considered in evaluating the clinical conditions of patients in tropical countries.


  • Open Access

    Disseminated Leishmaniasis Due to Using Immunosuppression Drugs: A Case Report

    by Maryam Afshoon, Mohammadreza Abdolsalehi, Golnaz Alinia, Katayoun Borhani, Bahareh Yaghmaie, Mahmoud Khodabandeh

    Visceral leishmaniasis is a common parasitic disease between humans and animals, transmitted by sandflies (Phlebotomus) in the Mediterranean countries, including Iran. The statistics have been reported less than real due to errors in the diagnosis and reporting of affected cases. In this report, we will present the symptoms and manifestations of this disease to reduce late detection and exacerbating factors. The patient was a three-year-old girl from Tehran, Iran who had ascites and hepatomegaly. When she was 9 month-old, she was diagnosed as autoimmune hepatitis after liver biopsy and she was treated with immunosuppressive drugs (Azathioprine, prednisolone, and cyclosporine) for 22 months, but later she suffered from fever, pancytopenia, and hepatosplenomegaly. Then a bone marrow biopsy was done for her. There was a large amount of Leishman body in her bone marrow and treatment for Kala-azar was started for her. In patients with prolonged fever and splenomegaly, especially association with pancytopenia, consider leishmaniasis. Immunosuppressive drugs can disseminate parasitic diseases, including visceral leishmaniasis.